The patient with Turner syndrome: Puberty and medical management concerns

Fertility and Sterility

Volumn 98, Issue 4, 2012, Pages 780-786

  Gonzalez, Luisa ^a   Witchel, Selma Feldman ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

aortic dissection; hormone replacement therapy; hypogonadism; Turner syndrome

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CYPROTERONE ACETATE; DESOGESTREL; DYDROGESTERONE; ESTRADIOL; ESTRIOL; ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; GESTAGEN; GESTODENE; GROWTH HORMONE; INHIBIN; OXANDROLONE; PLACEBO;

AORTA DISSECTION; AORTA RUPTURE; ARTICLE; AUTOIMMUNE DISEASE; BONE DENSITY; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD CARE; CLINICAL FEATURE; DELAYED PUBERTY; GROWTH CURVE; HEART DISEASE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; INFERTILITY; KARYOTYPE; KIDNEY MALFORMATION; LOW DRUG DOSE; OOCYTE DONATION; PREMATURE OVARIAN FAILURE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PUBERTY; SHORT STATURE; THROMBOPHILIA; THROMBOSIS; TURNER SYNDROME; ULTRASOUND; VENOUS THROMBOEMBOLISM;

EID: 84867032994     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.07.1104     Document Type: Review

References (56)

1. K. Stochholm, S. Juul, K. Juel, R.W. Naeraa, and C.H. Gravholt Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome J Clin Endocrinol Metab 91 2006 3897 3902
2. V.P. Sybert, and E. McCauley Turner's syndrome N Engl J Med 351 2004 1227 1238
3. J.E. Pinsker Turner syndrome: updating the paradigm of clinical care J Clin Endocrinol Metab 97 2012 E994 E1003
4. C.A. Bondy Turner Syndrome Study Group Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group J Clin Endocrinol Metab 92 2007 10 25
5. M.L. Davenport Approach to the patient with Turner syndrome J Clin Endocrinol Metab 95 2010 1487 1495
6. M. Clement-Jones, S. Schiller, E. Rao, R.J. Blaschke, A. Zuniga, and R. Zeller The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome Hum Mol Genet 9 2000 695 702
7. R.C. Knickmeyer Turner syndrome: advances in understanding altered cognition, brain structure and function Curr Opin Neurol 25 2012 144 149
8. M. Kocova, S.F. Siegel, M. Nalesnick, and M. Trucco Detection of Y-chromosome sequences in gonadal tissue of patients with Turner's syndrome (45, X) N Engl J Med 331 1994 682 683
9. C.S. Reh, and M.E. Geffner Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review Clin Pharmacol 2 2010 111 122
10. A. Linglart, S. Cabrol, P. Berlier, C. Stuckens, K. Wagner, and M. de Kerdanet Growth hormone treatment before the age of 4 years prevents short stature in young girls with Turner syndrome Eur J Endocrinol 164 2011 891 897
11. I.P. Hughes, C.S. Choong, M. Harris, G.R. Ambler, W.S. Cutfield, and P.L. Hofman Growth hormone treatment for Turner syndrome in Australia reveals that younger age and increased dose interact to improve response Clin Endocrinol (Oxf) 74 2011 473 480
12. M.B. Ranke, R. Schweizer, D.D. Martin, S. Ehehalt, C.P. Schwarze, and F. Serra Analyses from a centre of short- and long-term growth in Turner's syndrome on standard growth hormone doses confirm growth prediction algorithms and show normal IGF-I levels Horm Res Paediatr 77 2012 214 221
13. L.A. Matura, V. Sachdev, V.K. Bakalov, D.R. Rosing, and C.A. Bondy Growth hormone treatment and left ventricular dimensions in Turner syndrome J Pediatr 150 2007 587 591
14. S.D. Chernausek, K.M. Attie, J.F. Cara, R.G. Rosenfeld, and J. Frane Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group J Clin Endocrinol Metab 85 2000 2439 2445
15. J.L. Ross, Q.A. Quigley, D. Cao, P. Feuillan, K. Kowal, and J.J. Chipman Growth hormone plus childhood low dose estrogen in Turner's syndrome N Engl J Med 364 2011 1230 1242
16. E.J. Gault, R.J. Perry, T.J. Cole, S. Casey, W.F. Paterson, and P.C. Hindmarsh Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial BMJ 342 2011 d1980
17. C. Cunniff, K.L. Jones, and K. Benirschke Ovarian dysgenesis in individuals with chromosomal abnormalities Hum Genet 86 1991 552 556
18. F.A. Conte, M.M. Grumbach, and S.L. Kaplan A diphasic pattern of gonadotropin secretion in patients with the syndrome of gonadal dysgenesis J Clin Endocrinol Metab 40 1975 670 674
19. D. Chrysis, B.E. Spiliotis, M. Stene, E. Cacciari, and M.L. Davenport Gonadotropin secretion in girls with turner syndrome measured by an ultrasensitive immunochemiluminometric assay Horm Res 65 2006 261 266
20. I. Bryman, L. Sylvén, K. Berntorp, E. Innala, I. Bergström, and C. Hanson Pregnancy rate and outcome in Swedish women with Turner syndrome Fertil Steril 95 2011 2507 2510
21. T.N. Hadnott, H.N. Gould, A.M. Gharib, and C.A. Bondy Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience Fertil Steril 96 2011 2251 2256
22. C.P. Hagen, L. Aksglaede, K. Sorensen, K.M. Main, M. Boas, and L. Cleemann Serum levels of anti-müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients J Clin Endocrinol Metab 95 2010 5003 5010
23. C.P. Hagen, K.M. Main, S. Kjaergaard, and A. Juul FSH, LH, inhibin B and estradiol levels in Turner syndrome depend on age and karyotype: longitudinal study of 70 Turner girls with or without spontaneous puberty Hum Reprod 25 2010 3134 3141
24. M. Taboada, R. Santen, J. Lima, J. Hossain, R. Singh, and K.O. Klein Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndrome J Clin Endocrinol Metab 96 2011 3502 3510
25. M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, and M. El-Etr Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system Endocr Rev 28 2007 387 439
26. H.M. Fatemi, C. Bourgain, P. Donoso, C. Blockeel, E.G. Papanikolaou, and B. Popovic-Todorovic Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept Hum Reprod 22 2007 1260 1263
27. R. Sitruk-Ware, and A. Nath Metabolic effects of contraceptive steroids Rev Endocr Metab Disord 12 2011 63 75
28. G.S. Conway, M. Band, J. Doyle, and M.C. Davies How do you monitor the patient with Turner's syndrome in adulthood? Clin Endocrinol (Oxf) 73 2010 696 699
29. L. Cleemann, K. Holm, E. Fallentin, S.O. Skouby, H. Smedegaard, and N. Moller Uterus and ovaries in girls and young women with Turner syndrome evaluated by ultrasound and magnetic resonance imaging Clin Endocrinol (Oxf) 74 2011 756 761
30. F. Laliberté, K. Dea, M.S. Duh, K.H. Kahler, M. Rolli, and P. Lefebvre Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy Menopause 18 2011 1052 1059
31. M. Canonico, G. Plu-Bureau, G.D. Lowe, and P.Y. Scarabin Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis BMJ 336 2008 1227 1231
32. H. Deguchi, B.N. Bouma, S. Middeldorp, Y.M. Lee, and J.H. Griffin Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide J Thromb Haemost 3 2005 935 938
33. G.D. Lowe, M.N. Upton, A. Rumley, A. McConnachie, D.S. O'Reilly, and G.C. Watt Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein-a cross-sectional population survey Thromb Haemost 86 2001 550 556
34. V. Calcaterra, G. Gamba, N. Montani, A. de Silvestri, V. Terulla, and G. Lanati Thrombophilic screening in Turner syndrome J Endocrinol Invest 34 2011 676 679
35. C.H. Gravholt, K.H. Mortensen, N.H. Andersen, L. Ibsen, J. Ingerslev, and B.E. Hjerrild Coagulation and fibrinolytic disturbances are related to carotid intima thickness and arterial blood pressure in Turner syndrome Clin Endocrinol (Oxf) 76 2012 649 656
36. V. De Stefano, E. Rossi, K. Paciaroni, and G. Leone Screening for inherited thrombophilia: indications and therapeutic implications Haematologica 87 2002 1095 1108
37. C.C. Trenor 3rd, R.J. Chung, A.D. Michelson, E.J. Neufeld, C.M. Gordon, and M.R. Laufer Hormonal contraception and thrombotic risk: a multidisciplinary approach Pediatrics 127 2011 347 357
38. C. Trolle, B. Hjerrild, L. Cleemann, K.H. Mortensen, and C.H. Gravholt Sex hormone replacement in Turner syndrome Endocrine 41 2012 200 219
39. L. Cleemann, B.E. Hjerrild, A.L. Lauridsen, L. Heickendorff, J.S. Christiansen, and L. Mosekilde Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome Eur J Endocrinol 161 2009 251 257
40. V.K. Bakalov, and C.A. Bondy Fracture risk and bone mineral density in Turner syndrome Rev Endocr Metab Disord 9 2008 145 151
41. P. Christopoulos, E. Deligeoroglou, V. Laggari, S. Christogiorgos, and G. Creatsas Psychological and behavioural aspects of patients with Turner syndrome from childhood to adulthood: a review of the clinical literature J Psychosom Obstet Gynaecol 29 2008 45 51
42. R.C. Knickmeyer, and M. Davenport Turner syndrome and sexual differentiation of the brain: implications for understanding male-biased neurodevelopmental disorders J Neurodev Disord 3 2011 293 306
43. V.B. Ho, V.K. Bakalov, M. Cooley, P.L. Van, M.N. Hood, and T.R. Burklow Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features Circulation 110 2004 1694 1700
44. K.H. Mortensen, B.E. Hjerrild, N.H. Andersen, K.E. Sorensen, A. Horlyck, and E.M. Pedersen Abnormalities of the major intrathoracic arteries in Turner syndrome as revealed by magnetic resonance imaging Cardiol Young 20 2010 191 200
45. Mortensen KH, Andersen NH, Hjerrild BE, Horlyck A, Stochholm K, Gravholt CH. Carotid intima-media thickness is increased in Turner syndrome: multifactorial pathogenesis depending on age, blood pressure, cholesterol and oestrogen treatment. Clin Endocrinol (Oxf). Published online January 10, 2012.
46. J.E. Ostberg, A.E. Donald, J.P. Halcox, C. Storry, C. McCarthy, and G.S. Conway Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction J Clin Endocrinol Metab 90 2005 5161 5166
47. Carlson M, Silberbach M. Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature. BMJ Case Rep. 2009;2009:bcr0620091998.
48. K.H. Mortensen, B.E. Hjerrild, K. Stochholm, N.H. Andersen, K.E. Sorensen, and E. Lundorf Dilation of the ascending aorta in Turner syndrome - a prospective cardiovascular magnetic resonance study J Cardiovasc Magn Reson 13 2011 24
49. C.A. Bondy Aortic dissection in Turner syndrome Curr Opin Cardiol 23 2008 519 526
50. Practice Committee of the American Society for Reproductive Medicine Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome Fertil Steril 97 2012 282 284
51. R. Reindollar Turner syndrome contemporary thoughts and reproductive issues Semin Reprod Med 29 2011 342 352
52. L.A. Matura, V.B. Ho, D.R. Rosing, and C.A. Bondy Aortic dilatation and dissection in Turner syndrome Circulation 116 2007 1663 1670
53. A. Lleo, L. Moroni, L. Caliari, and P. Invernizzi Autoimmunity and turner's syndrome Autoimmun Rev 11 2012 A538 A543
54. K.H. Mortensen, L. Cleemann, B.E. Hjerrild, E. Nexo, H. Locht, and E.M. Jeppesen Increased prevalence of autoimmunity in Turner syndrome influence of age Clin Exp Immunol 156 2009 205 210
55. I. Bilge, H. Kayserili, S. Emre, A. Nayir, A. Sirin, and T. Tukel Frequency of renal malformations in Turner syndrome: analysis of 82 Turkish children Pediatr Nephrol 14 2000 1111 1114
56. K. Freriks, J. Timmermans, C.C. Beerendonk, C.M. Verhaak, R.T. Netea-Maier, and B.J. Otten Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome J Clin Endocrinol Metab 96 2011 E1517 E1526